Proactive - Interviews for investors

Argentina Lithium Vice President of Exploration Miles Rideout joined Steve Darling from Proactive to share positive results from the 12th exploration hole at the Rincon West Project in Salta Province, Argentina. Brine samples collected over a 165-meter interval of RW-DDH-012 ranged from 322 to 371 mg/l lithium. The Rincon West Project covers 5,198.8 hectares of the salar basin, consisting of three property blocks adjacent to Rio Tinto's Rincon Project.

Rideout explained to Proactive that drill hole RW-DDH-012 represents the third exploration hole of the 6-hole program planned for the Rinconcita II property. Currently, the company is completing access to the next drill platform, representing a further 1000-meter step towards the northeast corner of the property block. Samples collected between 48.5 meters depth and 213.5 meters depth (the deepest sample) ranged from 322 to 371 mg/l lithium. Over this 165-meter interval, 23 single packer brine samples were collected from discrete 3-meter intervals, totaling 69.0 meters of sampling, which represents 41.8% of the total interval.

#proactiveinvestors #argentinalithium&energycorp #tsxv #lit #otc #pnxlf

#MilesRideout, #LithiumMining, #ElectricVehicles, #RenewableEnergy, #BatteryProduction, #SustainableMining, #EnergyTransition, #GreenEnergy, #LithiumBattery, #ArgentinaEnergy, #MiningSector, #ResourceManagement, #EnvironmentalImpact, #CleanEnergy, #EnergyStorage, #ElectricCar, #LithiumMarket, #SustainableDevelopment, #EnergyCorp#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Greatland Gold PLC (AIM:GGP, OTC:GRLGF) managing director Shaun Day joins Proactive's Stephen Gunnion with details of a new exploration licence at the Ernest Giles project in Pilbara, Western Australia.

This area, known as the Eastern Goldfields, is largely unexplored and associated with significant global gold finds. The additional tenements consolidate the structural elements of Earnest Giles, covering the northern section of a geologically significant arc, enhancing Greatland Gold's control over this promising zone.

Day explained that these new tenements are part of an existing land access agreement, allowing rapid commencement of ground operations. For the remainder of the year, the company plans to drill at the Meadows target to the south and conduct electrical polarization surveys to refine targets in that region. Further north, near Mount Smith, they aim to define additional drill targets.

This expanded footprint at Ernest Charles marks a strategic consolidation, positioning Greatland Gold to capitalize on the geological potential of the area.

#GreatlandGold, #ShaunDay, #Mining, #GoldMining, #ErnestCharlesProject, #WesternAustralia, #Goldfields, #MineralExploration, #DrillingOperations, #Geology, #MiningIndustry, #ResourceConsolidation, #GreenstoneBelt, #GoldProspects, #LandAccess, #MiningUpdates, #ExplorationStrategy, #InvestInMining, #ResourceDevelopment, #MiningTechnology #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

U.S. Global Investors CEO Frank Holmes joined Steve Darling from Proactive to share an update on the company's Europe-domiciled airlines ETF, the U.S. Global Jets UCITS ETF, which has undergone a merger into the Travel UCITS ETF (TRIP). U.S. Global Investors acquired TRIP from HANetf, a leading provider of UCITS ETFs in Europe. It's important to note that TRIP is distinct from the U.S. online booking company TripAdvisor, which trades under the same ticker symbol (TRIP) on the Nasdaq.

Holmes explained that TRIP aims to track the Solactive Travel Index, which includes publicly-listed companies operating in the travel industry, such as airlines, hotels, travel agencies, and cruise lines. The inclusion of cruise lines in TRIP reflects the broader global travel investment theme, making it a strategic addition to U.S. Global Investors' product lineup.

According to data from the Cruise Lines International Association (CLIA), global cruise passenger volumes increased by nearly 7% from 2019 to 2023, with North America experiencing the strongest growth at 17.5%. This surge in demand for leisure travel has translated into higher revenues for cruise lines. In 2023, industry giants Carnival, Royal Caribbean, and Norwegian Cruise Line Holdings collectively reported approximately $44 billion in trailing 12-month net sales, up from $38.2 billion in pre-pandemic 2019.

The merger of U.S. Global Jets UCITS ETF into TRIP reflects the company's strategic approach to capturing opportunities in the evolving travel industry landscape, driven by increasing consumer demand and recovery from the pandemic's impact.

#proactiveinvestors #usglobalinvestors #airline #travel #oil #jets

#TravelETF, #Airlines, #CruiseLines, #StockMarket, #InvestmentStrategy, #QuantamentalInvesting, #PostCovidRecovery, #TravelBoom, #AirlineProfits, #TravelIndustry, #ETFMerger, #FrankHolmes, #CorporateStrategy, #InvestorInsights, #EconomicRecovery, #TransportationStocks, #StockAnalysis, #MarketTrends, #FinancialNews

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Immunic Inc chief medical officer Dr Andreas Muehler discusses the complexities of multiple sclerosis (MS) with Proactive's Stephen Gunnion to mark MS Awareness Week in the UK.

Dr Muehler described MS as a common autoimmune disease affecting around 4 million people globally, predominantly women diagnosed between ages 25 and 35. He detailed the two primary forms of MS: relapsing-remitting MS, experienced by approximately 80% of patients and characterized by unpredictable relapses, and primary progressive MS, which gradually worsens without relapses.

Dr Muehler also outlined the symptoms MS patients endure daily, such as debilitating fatigue and cognitive issues affecting their quality of life. During the interview, he focused on Immunic Inc's ongoing clinical trials for vidofludimus calcium, designed to address these symptoms. This drug exhibits anti-inflammatory, antiviral, and neuroprotective effects, potentially providing a new dimension in MS treatment.

Dr Muehler flagged upcoming trial results for Immunic's main programs in April 2025, with further significant updates expected in 2026.

#multiplesclerosisawareness #ImmunicInc, #MSAwareness, #AutoimmuneDisease, #MedicalResearch, #ClinicalTrials, #Healthcare, #Neurology, #WomenInMedicine, #MedicalInnovation, #PatientCare, #QualityOfLife, #AutoimmuneAwareness, #MSResearch, #NeurologicalDisorders, #MedicalScience, #HealthAndWellness, #DiseaseAwareness, #ChronicIllness, #MedicalCommunity #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

The FTSE 100 notched up yet another intraday high on Thursday morning of 8,093, continuing a strong week of trading for London’s blue chips.

Anglo American led gainers early on after news broke that the miner had received an unsolicited, all-share takeover offer from BHP.

AstraZeneca also saw strong gains in a busy day of earnings, after announcing a 22% increase in first-quarter operating profit to US$3.1 billion.

Barclays climbed as news of a 12% fall in first-quarter pre-tax profit to £2.27 billion on the back of softer net interest margins appeared not to hit sentiment.

Sainsbury’s fell in the meantime, having unveiled lower full-year profits against last year’s bumper figures, though did guide for the figure to surpass £1 billion in 2024 led by grocery sales growth.

#ProactiveInvestors #marketreport #ftse #ftse100 #footsie #angloamerican #bhp #astrazeneca #barclays #sainsburys #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Petros Pharmaceuticals CEO Fady Boctor joined Steve Darling from Proactive to share exciting developments with Proactive, highlighting a new collaboration with Lemonaid Health, a prominent telemedicine provider and subsidiary of 23andMe. Through this collaboration, Lemonaid Health's telehealth platform will offer prescription STENDRA® (avanafil) in all strengths, expanding distribution and enhancing access for patients. Lemonaid Health's extensive reach, having treated over 200,000 patients with erectile dysfunction (ED) to date, positions Petros to serve a broader patient base across the United States effectively.

In addition to the collaboration with Lemonaid Health, Boctor discussed the positive results of an initial cohort in Petros' self-selection study. This study compares the use of a Drug Facts Label (DFL) alone to a combination of DFL with a web app. The preliminary results suggest that while the DFL-alone approach may be insufficient for self-selection, the combination with the proposed technology significantly improves outcomes. This study serves as a precursor to Petros' pivotal Phase 2 study, initiated earlier this month, which aims to provide compelling evidence to the FDA. The pivotal study is designed to demonstrate that users can determine the appropriateness of STENDRA® (avanafil) without the need for a physician and prescription.

These developments underscore Petros Pharmaceuticals' commitment to leveraging innovative solutions to improve patient access to essential medications and streamline healthcare delivery processes.

#proactiveinvestors #petrospharmaceuticalsinc @nasdaq @ptpi

FadyBoctor, #OverTheCounterEDMedication, #PublicHealth, #AIHealthTech, #FDAApproval, #LemonadeHealth, #Telemedicine, #HealthcareInnovation, #ConsumerHealth, #SelfCare, #PharmaceuticalIndustry, #ErectileDysfunction, #HealthTech, #MedicalTechnology, #DrugApproval, #HealthcareAccess, #DigitalHealth, #PatientCare, #HealthcareTrends

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

RocketFuel Payment Solutions CEO Peter Jensen joined Steve Darling from Proactive to discuss the company's approach to leveraging blockchain technology for monetary transactions in an interview with Steve Darling from Proactive. Jensen highlighted the strategic use of stablecoins to facilitate efficient, transparent, and secure money transfers, particularly in business-to-business (B2B) transactions and payments to subsidiaries or vendors abroad, such as sending $50 million to Singapore.

One key advantage of stablecoins, according to Jensen, is their growing acceptance among large corporations that manage multi-currency accounts. These corporations can leverage stablecoins to access whichever currency is most favorable in different scenarios, enhancing flexibility and cost-effectiveness in cross-border transactions.

Jensen also touched on the broader economic and strategic implications of cryptocurrency adoption, likening it to the introduction of the euro. He noted the increasing strategic alliances among BRICS countries developing their own blockchain-based currencies as alternatives to the U.S. dollar, with the aim of achieving economic and strategic autonomy.

Furthermore, Jensen highlighted the widespread adoption of blockchain technology among major companies, citing partners like PayPal and Ripple. This integration reflects a broader trend toward the systemic incorporation of stablecoins into global financial practices, signaling the increasing importance of blockchain-based solutions in the modern economy.

#proactiveinvestors #rocketfuelinc #otcqb #rkfl #BlockchainIntegration#invest #investing

#Blockchain, #Stablecoins, #Cryptocurrency, #PeterJensen, #PaymentSolutions, #B2BTransactions, #GlobalFinance, #DigitalCurrency, #CryptoAdoption, #Fintech, #FinancialTechnology, #BRICs, #EconomicAutonomy, #MonetarySystems, #USDollarAlternative, #TransparencyInFinance, #MoneyTransfer, #BusinessStrategy, #TechInFinance

#investor #stockmarket #stocks #stock #stockmarketnews

MariMed CEO Jon Levine joined Steve Darling from Proactive to to share the Company’s significant developments, including its recent of Allgreens Dispensary, LLC, which closed on April 9, 2024. The acquisition enabled the Company to operate its 5th Thrive-branded dispensary in Illinois. It followed the recent opening of the Company’s processing facility in Mt. Vernon, Illinois, which enabled the Company to distribute its portfolio of top-selling brands throughout the high-growth state. Illinois surpassed $1.6 billion in adult-use cannabis sales last year, and MariMed looks to continue expanding there as current regulations in Illinois permit operators to own up to 10 dispensaries.

In addition to its expansion efforts in Illinois, MariMed has acquired the assets of Our Community Wellness & Compassionate Care Center in Prince George's County, Maryland. This acquisition marks MariMed's second adult-use Thrive Wellness dispensary in Maryland, complementing its existing location in Annapolis. The Company is vertically integrated in Maryland, with a cultivation and processing facility in Hagerstown that distributes MariMed products state-wide.

As a company dedicated to developing and distributing great brands and delivering an exceptional customer experience at its retail stores, these recent acquisitions underscore MariMed's commitment to strategic expansion and enhancing its footprint in key cannabis markets.

#proactiveinvestors #marimedinc #cse #mrmd #otcqx #mrmd

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Nevis Brands CEO John Kueber joined Steve Darling from Proactive to announce the successful completion of the initial production run of Major shots in Missouri through its licensee, Stash House Distro. This milestone marks the expansion of Nevis Brands' product offerings into the Missouri market, with three flavors of its 2-ounce Major shots—Fruit Punch, Blackberry Lemonade, and Blueberry—now available for sale. Nevis Brands has previously introduced these products in Washington and Ohio, achieving successful distribution.

The Major shots are infused with 100mg of THC and leverage a proprietary formula of flavor and emulsion technology, enabling rapid onset effects in under 20 minutes with minimal cannabis taste. The products are now accessible to consumers in numerous dispensaries across Missouri, further solidifying Nevis Brands' presence in the cannabis beverage market.

Additionally, Kueber shared news regarding the restructuring of the company's Promissory Note due to SoRSE Technology Corp., which was initially part of Nevis Brands' purchase of the SoRSE Technology business units "THC Essentials," including the Major brand. Under the revised terms of the agreement, Nevis Brands will pay USD $100,000 by April 30th, 2024, and proceed with periodic payments to retire the note principal by December 31, 2024. This strategic move reflects Nevis Brands' commitment to managing its financial obligations while continuing to expand its product portfolio and market presence.

#proactiveinvestors #nevisbrandsinc #cannabis #sorse #major #thc

#JohnKueber, #MissouriExpansion, #CannabisIndustry, #ProductLaunch, #MarketExpansion, #FinancialRestructuring, #BusinessGrowth, #RetailSales, #Dispensaries, #MissouriDispensaries, #MajorShots, #NewProduct, #BusinessStrategy, #CorporateFinance, #RegulatorySuccess, #MarketEntry, #StateExpansion, #CannabisProducts, #IndustryNews

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to shared exciting news about the launch of a new generation of buoy systems that mark significant advancements in the company's renewable energy technology. In an interview with Steve Darling from Proactive, Stratmann highlighted key features of these innovative buoy systems, which are designed to accommodate multiple renewable energy sources, including solar panels, wind turbines, and optionally, a wave power cartridge.

One of the most notable improvements is the modular, common equipment system, which eliminates the need for externally moving parts. This design change not only enhances deployment flexibility worldwide but also reduces costs and prices associated with these systems. Additionally, it expands the deployable areas to include regions with variable wave activity, such as the Gulf of Mexico, and even areas where wave power is absent, such as river outlets. This increased versatility allows for broader average power production across different marine and freshwater environments.

Stratmann also highlighted the significant reduction in R&D expenditures since November 2023, attributing this cost efficiency to the successful deployment and seasonal performance validations of the new buoy systems. He emphasized that these innovations are aligned with the growing global focus on zero-carbon solutions and the health of oceanic ecosystems, positioning Ocean Power Technologies as a key player in renewable energy conversations.

Overall, the launch of these new buoy systems represents a significant milestone for Ocean Power Technologies and underscores its commitment to advancing renewable energy technology while addressing environmental challenges.

#proactiveinvestors #oceanpowertechnologiesinc #nyseamerican #optt

#OceanPowerTechnologies, #RenewableEnergy, #GreenTech, #SustainableEnergy, #CleanEnergy, #ZeroCarbon, #OceanConservation, #WindPower, #SolarPower, #WaveEnergy, #EnvironmentalTech, #EcoFriendly, #ClimateAction, #Innovation, #EnergySolutions, #MarineTechnology, #WaterPower, #Renewables, #TechNews, #PhillipStratmann#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews